Budget cuts, delays to grant reviews, and layoffs of federal workers at agencies like the NIH and the National Science Foundation have affected nearly every research organization in the US. If ...
A recent study has demonstrated how RNA sequencing can enhance the genetic classification of B-cell precursor acute ...
When exposed to antibiotics, approximately one out of every 10 8 -10 9 bacteria develops resistance due to spontaneous ...
Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...
BMO Capital Markets analysts said the results potentially position lepodisiran as “one of the most durable assets in ...
Single-Molecule Footprinting reveals that RNA polymerase II (Pol II) occupancy is infrequent at mouse promoters. This results ...
Researchers at the University of Cologne have found that mRNA-based COVID-19 vaccines have a lasting impact on the innate ...
18hon MSN
Eli Lilly (NYSE:LLY) released positive Phase 2 results for its small interfering RNA (siRNA) drug candidate lepodisiran on ...
MedPage Today on MSN21h
siRNA Agent Slashes Lipoprotein(a) LevelsNovel small interfering RNA (siRNA) agent lepodisiran drastically cut levels of lipoprotein(a), or Lp(a), in the phase II ALPACA trial. The 400-mg dose cut Lp(a) by 93.9 percentage points compared ...
CHICAGO — Lepodisiran, a small interfering RNA agent, lowered lipoprotein(a) levels at 180 days, with a reduction of more ...
Quantbot Technologies LP acquired a new position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the ...
Researchers say they are exploring therapeutic options to block fatty acid accumulation and immunosuppressive signals between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback